Loading…
Fierce Drug Dev Forum 2019 has ended
Tuesday, October 29 • 11:45am - 12:30pm
Develop a Go-To-Market and Launch Strategy That Successfully Differentiates Your Launch Providing the Best Possible Access for Patients

Sign up or log in to save this to your schedule and see who's attending!

  • Determine the optimal timing in a product’s development cycle to begin launch preparations
  • Discuss key tactics to consider when developing a commercially and clinically viable differentiation strategy for a product
  • Hear how to build trust and interest, and ensure market development for your product ahead of a launch so you can hit the ground running
  • Leverage data-driven insights and analytics to identify the unique needs, preferences, and motivations of patient populations, and tailor key messaging to their expectations

Speakers
avatar for Randall Kaye, M.D.

Randall Kaye, M.D.

Chief Medical Officer, NEURANA PHARMACEUTICALS
avatar for Laura Saltonstall, M.D., MBA

Laura Saltonstall, M.D., MBA

Vice President, US and LATAM Medical Affairs, ALNYLAM PHARMACEUTICALS
Laura is Vice President, U.S. & LATAM Medical Affairs at Alnyalm where she is responsible for leading the U.S. and LATAM Medical Affairs organization across all therapeutic areas. Prior to joining Alnylam, Laura spent 14 years at Sanofi Genzyme where she was most recently Vice President... Read More →
avatar for Frank Sanders

Frank Sanders

Senior Vice President and General Manager, U.S. Commercial, SAGE THERAPEUTICS
avatar for Eric Warren

Eric Warren

Vice President, U.S. Cardiovascular (CV) Therapeutic Area Head, SANOFI


Tuesday October 29, 2019 11:45am - 12:30pm